Transgenic mice overexpressing insulin-like growth factor-II in β cells develop type 2 diabetes

Journal of Clinical Investigation

Volumn 105, Issue 6, 2000, Pages 731-740

  Devedjian, Jean Christophe ^a   George, Monica ^a   Casellas, Alba ^a   Pujol, Anna ^a   Visa, Joana ^a   Pelegrín, Mireia ^a   Gros, Laurent ^a   Bosch, Fatima ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; INSULIN; MESSENGER RNA; SOMATOMEDIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FATTY LIVER; GROWTH REGULATION; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0034063375     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5656     Document Type: Article

References (59)

1. LeRoith, D. 1991. Insulin-like growth factors: molecular and cellular aspects. CRC Press. Boca Raton, FL.
2. Schofield, P.N. 1992. The insulin-like growth factors: structure and biological function. Oxford University Press. Oxford, United Kingdom.
3. Le Roith, D. 1997. Insulin-like growth factors. N. Engl. J. Med. 336:633-640.
4. Han, V.K., Lund, P.K., Lee, D.C., and D'Ercole, A.J. 1988. Expression of somaromedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J. Clin. Endocrinol. Metab. 66:422-429.
5. Hogg, J., Han, V.K.M., Clemmons, D.H., and Hill, D.J. 1993. Interactions of nutrients, insulin-like growth factors (IGFs) and IGF-binding proteins in the regulation of DNA synthesis by isolated fetal rat islets of Langerhans. J. Endocrinol. 138:401-412.
6. Rabinovitch, A., Quigley, C., Russell, T., Patel, Y., and Mintz, D.H. 1982. Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet beta-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes. 31:160-164.
7. Maake, C., and Reinecke, M. 1993. Immunohistochemical localization of insulin-like growth factor 1 and 2 in the endocrine pancreas of rat, dog, and man, and their coexistence with classical islet hormones. Cell Tissue Res. 273:249-259.
8. Hoog, A., et al. 1996. Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats. Endocrinology. 137:2415-2423.
9. Hoog, A., et al. 1997. Ultrastructural localization of insulin-like growth factor-2 (IGF-2) to the secretory granules of insulin cells: a study in normal and diabetic (GK) rats. Ultrastruct. Pathol. 21:457-466.
10. Polonsky, K.S., Sturis, J., and Bell, G.I. 1996. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334:777-783.
11. De Fronzo, R.A. 1997. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetic genes. Diabetes Reviews. 5:177-269.
12. McGarry, J.D. 1992. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 258:766-770.
13. Lillioja, S., et al. 1991. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 73:866-876.
14. Le Stunff, C., and Bougneres, P. 1992. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes. 43:696-702.
15. Jeanrenaud, B. 1994. Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM Diabetologia. 37(Suppl. 2):S170-S178.
16. Zarjevski, N., Doyle, P., and Jeanrenaud, B. 1992. Muscle insulin resistance may not be a primary etiological factor in the genetically obese fa/fa rat. Endocrinology. 130:1564-1570.
17. Kanery, H., Moshe, S., Shafrir, E., Lunenfeld, B., and Karasik, A. 1994. Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 91:1853-1857.
18. Del Prato, S., et al. 1994. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia. 37:1025-1035.
19. Pontiroli, A.E., Alberetto, M., and Pozza, G. 1992. Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetalogia. 35:294-295.
20. Skrha, J., Sindelka, G., Haas, T., Hilgertova, J., and Justova, V. 1996. Comparison of insulin sensitivity in patients with insulinoma and obese Type 2 diabetes mellitus. Horm. Metab. Res. 28:595-598.
21. Marban, S.L., DeLoia, J.A., and Gearhart, J.D. 1989. Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene. Dev. Genet. 10:356-364.
22. Marban, S.L. 1992. Hyperinsulinemia precedes insulin resistance in transgenic mouse model of type II diabetes. Diabetes. 41(Suppl.):145A. (Abstr.)
23. Stempien, M.M., Fong, N.M., Rall, L.B., and Bell, G.I. 1986. Sequence of a placental cDNA encoding the mouse insulin-like growth factor II precursor. DNA. 5:357-361.
24. Valera, A., et al. 1994. Expression of Glut-2 antisense RNA in β-cells of transgenic mice leads to diabetes. J. Biol. Chem. 269:28543-28546.
25. Hogan, B., Costantini, F., and Lacy, F. 1986. Manipulating the mouse embryo. A laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, NY. 157-173.
26. Chirgwin, J.M., Przybyla, A.W., McDonald, R.J., and Rutter, W.J. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry. 18:5294-5299.
27. Lacy, P.E., and Kostianousky, M. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 16:35-39.
28. Ashcroft, S.J., Weeransinghe, L.C.C., Bassett, J.M., and Randle, P.J. 1972. The pentose cycle and insulin release in mouse pancreatic islets. Biochem. J. 126:525-532.
29. Fehmann, H.C., Jehle, P., Markus, U., and Goke, B. 1996. Functional active receptors for insulin-like growth factor-1 (IGF-I) and IGH-II on insulin-glucagon-, and somatostatin-producing cells. Metabolism. 45:759-766.
30. Tokuyama, Y., et al. 1995. Involution of β-cell dysfunction in the male Zucker diaberic fatty rat. Diabetes, 44:1447-1457.
31. Polonsky, K.S. 1995. The β-cell in diabetes: from molecular genetics to clinical research. Diabetes. 44:705-717.
32. Larsson, L.I., Boder, G.B., and Shaw, W.N. 1977. Changes in the islets of Langerhans in the obese Zucker rat. Lab. Invest. 36:593-598.
33. Shino, A., Matsueo, T., Iwatsuka, H., and Zizuki, Z. 1973. Structural changes of pancreatic islets in genetically obese rats. Diabetologia. 9:413-421.
34. Like, A.A., and Chick, W.L. 1970. Studies in the diabetic mutant mouse: electron microscopy of pancreatic islets. Diabetologia. 6:216-242.
35. Van Schravendijk, C.F.H., Foriers, A., Van den Brande, J.L., and Pipeleers, D.G. 1987. Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology. 121:1784-1788.
36. Withers, D.J., et al. 1999. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling. Nat. Genet. 23:32-40.
37. Coleman, D.L., and Hummel, K.P. 1973. The influence of genetic background on the expression of the obese (ob) gene in the mouse. Diabetologia. 9:287-293.
38. Bruning, J.C., et al. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 21:561-572.
39. Bonner-Weir, S., Deery, D., Leahy, J.L. and Weir, G.C. 1989. Compensatory growth of pancreatic B-cells in adult rats after short term glucose infusion. Diabetes. 38:49 -53.
40. Araki, E., et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190.
41. Tamemoto, H., et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:182-186.
42. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes. Nature. 391:300-903.
43. De Meyts, P., et al. 1994. The insulin-like growth factor-1 receptor. Structure, ligand-binding mechanism and signal transduction. Horm. Res. 42:152-169.
44. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C.T. 1995. Molecular and cellular aspects of the insulin-like growth factor 1 receptor. Endocr. Rev. 16:143-163.
45. Mottola, C., and Czech, M.P. 1984. The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells. J. Biol. Chem. 259:12705-12713.
46. Haig, D., and Graham, C. 1991. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell. 64:1045-1046.
47. Forejt, J., and Gregorova, S. 1992. Genetic analysis of genomic imprinting: an imprintor-1 gene controls inactivation of the paternal copy of the mouse Tme locus. Cell. 70:443-450.
48. Morrione, A., et al. 1997. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. Natl. Acad. Sci. USA. 94:3777-3782.
49. Kulkarni, R.N., et al. 1999. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
50. Valera, A., et al. 1993. Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene. FASEB J. 7:791-800.
51. Petrik, J., et al. 1999. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hiperplasia. Endocrinology. 140:2353-2363.
52. Cohen, P., et al. 1992. Insulin-like growth factors (IGFs): implications for aging. Psyconeuroendocrinology. 17:335-342.
53. Rogler, C.E., et al. 1994. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factos-II transgenic mice. J. Biol. Chem. 269:13779-13784.
54. Rossetti, L., et al. 1996. Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J. Biol. Chem. 271:203-208.
55. Leahy J.L., and Vandekerkhove, K.M. 1990. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology. 126:1593-1598.
56. Dheen, S.T., Kajkumar, K., and Murphy, L.J. 1996. Effects of insulin-like growth factors (IGF) on pancreatic islet function in IGF binding protein-1 transgenic mice. Diabetologia. 39:1249-1254.
57. Unger, R.H. 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes. 44:863-870.
58. Lee, Y., et al. 1994. β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc. Natl. Acad. Sci. USA. 91:10878-10882.
59. Milburn, J.L., et al. 1995. Pancreatic β-cell in obesity. J. Biol. Chem. 270:1295-1299.